We interviewed Sharon Brownlow from the Cell & Gene Therapy Catapult on the top trends in cell therapy

We interview Sharon Brownlow, Chief Business Officer at the Cell & Gene Therapy Catapult, which is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry. Sharon led the commercial operations at the CGT Catapult manufacturing centre in Stevenage for over three years. In this time, she played a pivotal role in securing collaborative research funding with partners and supporting the growth and productivity of the Manufacturing Centre. 

In part 1 of this interview, we find out more about Sharon’s career in biopharma and her focus at the Cell & Gene Therapy Catapult.

In part 2 of this interview, Sharon talks about the biggest opportunities in the cell and gene field for growth, and where the industry’s priorities need to lie in the coming years.

As well as delivering the opening and closing remarks, Sharon also facilitated the session ‘supply pain’ at our 2021 Advanced Therapies Integrates event.